Multiple ETF Products Approved Sequentially; Shanghai Stock Exchange Continuously Enriches New Quality Productive Force Investment Tools

MetaMuskRat · 2026-03-20T20:19:30+00:00

People's Finance News, March 19 — Recently, more than a dozen ETF products, including three China Securities Innovation and Entrepreneurship AI ETFs, have been successively approved and are expected to be listed and issued on the Shanghai Stock Exchange in the near future. The launch of relevant products will further expand investment channels for investors to participate in cultivating new productive forces, and the precision of capital markets in serving the development of the real economy will continue to improve. With the deepening advancement of a series of reform measures in the capital market, the Shanghai Stock Exchange will continue to build a multi-level and three-dimensional ETF market system and product service matrix, and will play a more critical role in guiding medium and long-term capital to concentrate in the field of technological innovation.

MetaMuskRat

2026-03-20 20:19:30

People’s Financial News, March 19 — Recently, more than ten ETF products, including three CSI Science and Technology Innovation and Entrepreneurship Artificial Intelligence ETFs, have been approved and are expected to be listed on the Shanghai Stock Exchange soon. The launch of these products will further expand investors’ channels to participate in the cultivation of new productive forces, and the precision of capital market services for the real economy continues to improve. As a series of reform measures in the capital market are further implemented, the Shanghai Stock Exchange continues to build a multi-level, three-dimensional ETF market system and product service matrix, which will play a more critical role in guiding medium- and long-term funds to gather in the field of technological innovation.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.